Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 14/20 | 0.44 |
| ▸ | CTSS | P25774 | 13/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CTSL | P07711 | 2/20 | 0.42 |
| ▸ | CTSB | P07858 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2401413 | 1.00 | CTSK (0.44) | CTSKCTSSCA1CA2CA7 | |
| SCHEMBL8719643 | 0.86 | CYP2D6 (0.54) | CTSKCTSSCA1CA2CA7 | |
| SCHEMBL3498621 | 0.86 | CYP2D6 (0.54) | CTSKCTSSCA1CA2CA7 | |
| SCHEMBL26110455 | 0.85 | CTSS (0.50) | CTSKCTSSCA1CA2CA7 | |
| SCHEMBL26110452 | 0.85 | CTSS (0.50) | CTSKCTSSCA1CA2CA7 | |
| SCHEMBL6769450 | 0.85 | CTSK (0.43) | CTSKCTSSCA1CA2CA7 | |
| SCHEMBL6633918 | 0.85 | CTSK (0.43) | CTSKCTSSCA1CA2CA7 | |
| SCHEMBL16762943 | 0.85 | CTSK (0.43) | CTSKCTSSCA1CA2CA7 | |
| SCHEMBL27926619 | 0.85 | CTSK (0.43) | CTSKCTSSCA1CA2CA7 | |
| SCHEMBL2719723 | 0.85 | CTSS (0.50) | CTSKCTSSCA1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109010830-A | Application of the blood platelet related inhibitors in preparation treatment decrease of platelet disease drug | 苏州大学 | 2018-12-18 | — | — | CN | claimed |
| CN-1889974-A | Oligopeptides as coating material for medical products | HEMOTEQ GMBH (DE) | 2007-01-03 | — | — | CN | claimed |
| CN-109010830-B | Application of platelet related inhibitor in preparation of medicine for treating thrombocytopenia | 苏州大学 | 2022-06-07 | — | — | CN | disclosed |
| CN-109010830-A | Application of the blood platelet related inhibitors in preparation treatment decrease of platelet disease drug | 苏州大学 | 2018-12-18 | — | — | CN | disclosed |
| CN-1889974-B | Oligopeptides as coating material for medical products | HEMOTEQ GMBH | 2012-08-29 | — | — | CN | disclosed |
| CN-1889974-A | Oligopeptides as coating material for medical products | HEMOTEQ GMBH (DE) | 2007-01-03 | — | — | CN | disclosed |
| US-4596790-A | Pharmaceuticals | NYEGAARD & CO. A/S (NO) | 1986-06-24 | — | — | US | disclosed |
| EP-0156063-A2 | Hypoglycaemic tetrapeptides | Reichelt, Karl Ludvig (NO) | 1985-10-02 | — | — | EP | disclosed |